SCHEMBL24614682

SCHEMBL24614682

c1ccc(-c2c3ccccc3c(-c3cc4cc(-c5c6ccccc6c(-c6cccc(-c7ccc8ccccc8c7)c6)c6ccccc56)c5sc6ccccc6c5c4c4c3sc3ccccc34)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 8/20 0.36
S1PR4 O95977 6/20 0.36
HSD17B1 P14061 2/20 0.35
HSD17B2 P37059 2/20 0.35
GPR84 Q9NQS5 1/20 0.34
PTPN1 P18031 2/20 0.34
ALOX5 P09917 1/20 0.34
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2B6 P20813 1/20 0.32
CYP2C19 P33261 1/20 0.32
CYP1A1 P04798 1/20 0.32
CYP1B1 Q16678 1/20 0.32
TNKS O95271 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
PTPRC P08575 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24614686 0.96 GPR84 (0.36) S1PR5S1PR4GPR84PTPN1ALOX5
SCHEMBL24614753 0.92 PTPN1 (0.37) HSD17B1HSD17B2PTPN1ALOX5ESR1
SCHEMBL24614940 0.91 HSD17B1 (0.33) S1PR5S1PR4HSD17B1HSD17B2GPR84
SCHEMBL24614934 0.88 PTPN1 (0.35) PTPN1ALOX5ESR1ESR2CYP1A1
SCHEMBL24614750 0.88 PTPN1 (0.39) GPR84PTPN1ALOX5ESR1ESR2
SCHEMBL24614685 0.88 PTPN1 (0.41) PTPN1ALOX5ESR1ESR2TNKS
SCHEMBL24614677 0.87 F9 (0.37) S1PR5S1PR4GPR84PTPN1ALOX5
SCHEMBL17944615 0.87 ALOX5 (0.37) S1PR5S1PR4HSD17B1HSD17B2GPR84
SCHEMBL24614768 0.87 PTPN1 (0.40) GPR84PTPN1ALOX5TNKSTNKS2
SCHEMBL24614804 0.86 MAPT (0.34) S1PR5S1PR4GPR84PTPN1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES TMEM109, PIEZO1, L1CAM S1PR5 4028/4885S1PR4 3875/4885HSD17B1 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.